In murine sepsis, reduced mRNA expression of PPARα and its targets involved in FFA β-oxidation could indeed be linked to a reduced capability of liver explants to metabolize palmitic acid ex vivo, as measured with the Seahorse technology [12]. The gene discussed is PPARA; the disease is Sepsis.